Eddit
Zeile 6: | Zeile 6: | ||
*'''[[Reviews on covid19 disease]]''' | *'''[[Reviews on covid19 disease]]''' | ||
+ | {{tp|p=32122636|t=2020. (mayo)Guide to Understanding the 2019 Novel Coronavirus |pdf=|usr=}} | ||
+ | |||
+ | |||
*'''[[Clinical guidelines and advice]]''' | *'''[[Clinical guidelines and advice]]''' | ||
{{tp|p=32413768|t=2020. Covert COVID-19 complications: Continuing the use of evidence-based drugs to minimize potentially lethal indirect effects of the pandemic in stroke patients |pdf=|usr=}} | {{tp|p=32413768|t=2020. Covert COVID-19 complications: Continuing the use of evidence-based drugs to minimize potentially lethal indirect effects of the pandemic in stroke patients |pdf=|usr=}} | ||
− | + | {{tp|p=32416414|t=2020. Genetic predisposition models to COVID-19 infection |pdf=|usr=}} | |
Zeile 14: | Zeile 17: | ||
{{tp|p=C7200124|t=ä. Airway management for COVID-19: a move towards universal videolaryngoscope?|pdf=|usr=}} | {{tp|p=C7200124|t=ä. Airway management for COVID-19: a move towards universal videolaryngoscope?|pdf=|usr=}} | ||
{{tp|p=32444270|t=ä. Considerations for ventilator triage during the COVID-19 pandemic |pdf=|usr=}} | {{tp|p=32444270|t=ä. Considerations for ventilator triage during the COVID-19 pandemic |pdf=|usr=}} | ||
− | + | {{tp|p=30642777|t=2019. ECMO in severe acute respiratory distress syndrome |pdf=|usr=}} | |
− | + | {{tp|p=25209989|t=2014. ECMO as an emergency medical countermeasure |pdf=|usr=}} | |
*'''[[Diagnosis (Laboratory)]]''' | *'''[[Diagnosis (Laboratory)]]''' | ||
{{tp|p=32006218|t=ä. Clinical role of viral identification by a polymerase chain reaction-based diagnostic panel in adults hospitalized with community-acquired pneumonia |pdf=|usr=}} | {{tp|p=32006218|t=ä. Clinical role of viral identification by a polymerase chain reaction-based diagnostic panel in adults hospitalized with community-acquired pneumonia |pdf=|usr=}} | ||
{{tp|p=C7194818|t=ä. Pooling of samples for testing for SARS-CoV-2 in asymptomatic people |pdf=|usr=}} | {{tp|p=C7194818|t=ä. Pooling of samples for testing for SARS-CoV-2 in asymptomatic people |pdf=|usr=}} | ||
− | + | {{tp|p=32466975|t=ä. Rapid immunoglobulin test confirms a suspected case of COVID-19 |pdf=|usr=}} | |
*'''[[Diagnosis (Lung CT, Sonography)]]''' | *'''[[Diagnosis (Lung CT, Sonography)]]''' | ||
− | + | {{tp|p=C7190512|t=ä. El diagnostico COVID-19 a travs de la imagen |pdf=|usr=}} | |
− | + | {{tp|p=32402387|t=ä. ...ct thorax...|pdf=|usr=}} | |
*'''[[Diagnosis (other modalities)]]''' | *'''[[Diagnosis (other modalities)]]''' | ||
{{tp|p=32421627|t=2020. The impact of biosensing in a pandemic outbreak: COVID-19 |pdf=|usr=}} | {{tp|p=32421627|t=2020. The impact of biosensing in a pandemic outbreak: COVID-19 |pdf=|usr=}} | ||
{{tp|p=C7197557|t=ä. Selecting a SARS-CoV-2/COVID molecular testing method for your laboratory |pdf=|usr=}} | {{tp|p=C7197557|t=ä. Selecting a SARS-CoV-2/COVID molecular testing method for your laboratory |pdf=|usr=}} | ||
− | --- | + | {{tp|p=32417029|t=ä. Pre- and post-treatment chest CT changes in a patient with COVID-19 |pdf=|usr=}} |
Zeile 52: | Zeile 55: | ||
{{ttp|p=32073157|t=2020. Antibodies to coronaviruses are higher in older compared with younger adults and binding antibodies are more sensitive than neutralizing antibodies in identifying coronavirus?associated illnesses |pdf=|usr=}} | {{ttp|p=32073157|t=2020. Antibodies to coronaviruses are higher in older compared with younger adults and binding antibodies are more sensitive than neutralizing antibodies in identifying coronavirus?associated illnesses |pdf=|usr=}} | ||
{{tp|p=30715745|t=2019. (+)Th17 serum cytokines in relation to laboratory?confirmed respiratory viral infection: A pilot study |pdf=|usr=}} | {{tp|p=30715745|t=2019. (+)Th17 serum cytokines in relation to laboratory?confirmed respiratory viral infection: A pilot study |pdf=|usr=}} | ||
− | + | {{ttp|p=32408068|t=2020. What about the original antigenic sin of the humans versus SARS-CoV-2?|pdf=|usr=}}''the term «original antigenic sin» (OAS) was coined by T. Francis Jr at the Michigan University in the late 1950s to describe patterns of antibody response to influenza vaccination...'' | |
*'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' | *'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' | ||
Zeile 65: | Zeile 68: | ||
*'''[[Similar diseases and pathomechanisms]]''' | *'''[[Similar diseases and pathomechanisms]]''' | ||
− | + | {{tp|p=C7149537|t=2008. (mech resp)Severe Acute Respiratory Syndrome (SARS) |pdf=|usr=}} | |
− | + | {{tp|p=32145185|t=2020. Middle East respiratory syndrome |pdf=|usr=}} | |
*'''[[Early symptoms]]''' | *'''[[Early symptoms]]''' | ||
Zeile 80: | Zeile 83: | ||
*'''[[Pulmonary embolism, coagulation]]''' | *'''[[Pulmonary embolism, coagulation]]''' | ||
{{tp|p=C7190290|t=ä. (On embolism)Progressive respiratory failure in COVID-19: a hypothesis |pdf=|usr=}} | {{tp|p=C7190290|t=ä. (On embolism)Progressive respiratory failure in COVID-19: a hypothesis |pdf=|usr=}} | ||
+ | {{tp|p=C7177114|t=2020. Hypoxia in COVID-19: Sign of Severity or Cause for Poor Outcomes |pdf=|usr=}} | ||
+ | {{tp|p=32376101|t=2020. Association Between Hypoxemia and Mortality in Patients With COVID-19 |pdf=|usr=}} | ||
+ | |||
*'''[[Hematology]]''' | *'''[[Hematology]]''' | ||
Zeile 86: | Zeile 92: | ||
*'''[[Heart]]''' | *'''[[Heart]]''' | ||
− | + | {{tp|p=32448590|t=ä. Marked Up-Regulation of ACE2 in Hearts of Patients With Obstructive Hypertrophic Cardiomyopathy: Implications for SARS-CoV-2 Mediated COVID-19 |pdf=|usr=}} | |
− | + | {{tp|p=32446685|t=ä. Acute pericarditis due to COVID-19 infection: An underdiagnosed disease?|pdf=|usr=}} | |
*'''[[Neurology, ophthalmology, orl]]''' | *'''[[Neurology, ophthalmology, orl]]''' | ||
− | + | {{tp|p=32289035|t=2020. Dysosmia and dysgeusia due to the 2019 Novel Coronavirus; a hypothesis that needs further investigation |pdf=|usr=}} | |
*'''[[Dermatology]]''' | *'''[[Dermatology]]''' | ||
− | + | {{tp|p=32402385|t=ä. Manifestaciones cutaneas ... un caso |pdf=|usr=}} | |
Zeile 100: | Zeile 106: | ||
{{tp|p=32096611|t=2020. 2019 Novel coronavirus infection and gastrointestinal tract |pdf=|usr=}} | {{tp|p=32096611|t=2020. 2019 Novel coronavirus infection and gastrointestinal tract |pdf=|usr=}} | ||
{{tp|p=32387057|t=ä. SARS-CoV-2 infection may result in appendicular syndrome: Chest CT scan before appendectomy |pdf=|usr=}} | {{tp|p=32387057|t=ä. SARS-CoV-2 infection may result in appendicular syndrome: Chest CT scan before appendectomy |pdf=|usr=}} | ||
+ | {{tp|p=32377565|t=ä. COVID-19 and gastrointestinal tract |pdf=|usr=}} | ||
+ | |||
+ | |||
+ | |||
*'''[[Kidney, urology]]''' | *'''[[Kidney, urology]]''' | ||
− | + | {{ttp|p=32204907|t=2020. The Novel Coronavirus 2019 epidemic and kidneys |pdf=|usr=}} | |
Zeile 110: | Zeile 120: | ||
{{tp|p=32388230|t=2020. Covid-19 infection in therapy-naive patients with B-cell chronic lymphocytic leukemia |pdf=|usr=}} | {{tp|p=32388230|t=2020. Covid-19 infection in therapy-naive patients with B-cell chronic lymphocytic leukemia |pdf=|usr=}} | ||
{{tp|p=32389426|t=2020. A favorable outcome of pneumonia COVID 19 in an advanced lung cancer patient with severe neutropenia: ...|pdf=|usr=}} | {{tp|p=32389426|t=2020. A favorable outcome of pneumonia COVID 19 in an advanced lung cancer patient with severe neutropenia: ...|pdf=|usr=}} | ||
+ | {{tp|p=32376099|t=2020. Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019 |pdf=|usr=}} | ||
+ | {{tp|p=32475616|t=ä. copd w covid.... |pdf=|usr=}} | ||
*'''[[Case reports]]''' | *'''[[Case reports]]''' | ||
{{tp|p=32232784|t=ä. A woman with fever and cough: coronavirus disease 2019 |pdf=|usr=}} | {{tp|p=32232784|t=ä. A woman with fever and cough: coronavirus disease 2019 |pdf=|usr=}} | ||
+ | {{tp|p=32061312|t=2020. First imported case of 2019 novel coronavirus in Canada, presenting as mild pneumonia |pdf=|usr=}} | ||
+ | |||
+ | |||
*'''[[Case series]]''' | *'''[[Case series]]''' | ||
{{tp|p=32123993|t=ä. Clinical features and short-term outcomes of 18 patients with corona virus disease 2019 in intensive care unit |pdf=|usr=}} | {{tp|p=32123993|t=ä. Clinical features and short-term outcomes of 18 patients with corona virus disease 2019 in intensive care unit |pdf=|usr=}} | ||
{{tp|p=32092387|t=2020. Clinical features of atypical 2019 novel coronavirus pneumonia with an initially negative RT-PCR assay |pdf=|usr=}} | {{tp|p=32092387|t=2020. Clinical features of atypical 2019 novel coronavirus pneumonia with an initially negative RT-PCR assay |pdf=|usr=}} | ||
− | + | {{tp|p=32451119|t=2020. The Early Natural History of SARS-CoV-2 Infection: Clinical Observations From an Urban, Ambulatory COVID-19 Clinic |pdf=|usr=}} | |
Zeile 124: | Zeile 139: | ||
{{tp|p=32377641|t=2020. Initial data from the COVID-19 Global Rheumatology Alliance provider registries |pdf=|usr=}} | {{tp|p=32377641|t=2020. Initial data from the COVID-19 Global Rheumatology Alliance provider registries |pdf=|usr=}} | ||
{{tp|p=32377642|t=2020. Initial data from the COVID-19 Global Rheumatology Alliance provider registries ? Authors reply |pdf=|usr=}} | {{tp|p=32377642|t=2020. Initial data from the COVID-19 Global Rheumatology Alliance provider registries ? Authors reply |pdf=|usr=}} | ||
− | + | {{tp|p=32353329|t=2020. An international registry for emergent pathogens and pregnancy |pdf=|usr=}} | |
Zeile 137: | Zeile 152: | ||
{{tp|p=32380023|t=ä. Immunomodulation in COVID-19 |pdf=|usr=}} | {{tp|p=32380023|t=ä. Immunomodulation in COVID-19 |pdf=|usr=}} | ||
{{tp|p=32444269|t=ä. Immunotherapies for COVID-19: lessons learned from sepsis |pdf=|usr=}} | {{tp|p=32444269|t=ä. Immunotherapies for COVID-19: lessons learned from sepsis |pdf=|usr=}} | ||
+ | {{tp|p=32409074|t=2020. An overview of functional nanoparticles as novel emerging antiviral therapeutic agents |pdf=|usr=}} | ||
+ | {{tp|p=C7190528|t=ä. Treatment Considerations for COVID-19: A Critical Review of the Evidence (or Lack Thereof) |pdf=|usr=}} | ||
+ | {{tp|p=32386744|t=ä. Uso de antipaludicos (antimalarials)...|pdf=|usr=}} | ||
+ | {{tp|p=32408073|t=2020. Lithium for the 2019 novel coronavirus |pdf=|usr=}} | ||
+ | {{tp|p=32416413|t=2020. Covid-19 management with inflammation resolving mediators? Perspectives and potential |pdf=|usr=}} | ||
+ | {{tp|p=32408070|t=2020. Does zinc supplementation enhance the clinical efficacy of chloroquine/hydroxychloroquine to win todays battle against COVID-19?|pdf=|usr=}} | ||
+ | {{tp|p=32373787|t=2020. A new paradigm for drug development |pdf=|usr=}} | ||
+ | {{tp|p=32359447|t=2020. The resurgence of convalescent plasma therapy |pdf=|usr=}} | ||
+ | {{tp|p=32325038|t=ä. (+)Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial |pdf=|usr=}} | ||
+ | {{tp|p=32325036|t=ä. Two Middle East respiratory syndrome vaccines: first step for other coronavirus vaccines?|pdf=|usr=}} | ||
+ | {{ttp|p=29329956|t=2018. Herd immunity: hyperimmune globulins for the 21st century |pdf=|usr=}}''megapool for the top useful human mab'' | ||
+ | {{tp|p=31351923|t=2019. (+)First clinical trial of a MERS coronavirus DNA vaccine |pdf=|usr=}} | ||
+ | {{tp|p=28664850|t=2017. (+)Novel translational approaches to the search for precision therapies for acute respiratory distress syndrome |pdf=|usr=}} | ||
+ | {{tp|p=32373790|t=2020. Silencing the cytokine storm: the use of intravenous anakinra in haemophagocytic lymphohistiocytosis or macrophage activation syndrome |pdf=|usr=}} | ||
+ | {{tp|p=29852530|t=2020. The expanding role of mass spectrometry in the field of vaccine development |pdf=|usr=}} | ||
Zeile 155: | Zeile 185: | ||
{{tp|p=32416433|t=2020. Metronomic oral vinorelbine and lung cancer therapy during the COVID 19 pandemic: A single-center experience |pdf=|usr=}} | {{tp|p=32416433|t=2020. Metronomic oral vinorelbine and lung cancer therapy during the COVID 19 pandemic: A single-center experience |pdf=|usr=}} | ||
{{tp|p=C7202360|t=ä. Lung cancer management challenges amidst COVID-19 pandemic: hope lives here |pdf=|usr=}} | {{tp|p=C7202360|t=ä. Lung cancer management challenges amidst COVID-19 pandemic: hope lives here |pdf=|usr=}} | ||
+ | {{tp|p=C7200366|t=2020. Managing thromboembolic risk with menopausal hormone therapy and hormonal contraception....|pdf=|usr=}} | ||
+ | {{tp|p=32414550|t=2020. ST-segment Elevation, Myocardial Injury, and Suspected or Confirmed COVID-19 Patients: Diagnostic and Treatment Uncertainties |pdf=|usr=}} | ||
+ | {{tp|p=32376104|t=2020. Public Health Crises and the Human Subjects of Biomedical Research: A Focus on COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32343347|t=ä. A Simple Technique for Droplet Control During Mastoid Surgery |pdf=|usr=}} | ||
+ | {{tp|p=32043976|t=2020. A contingency plan for the management of the 2019 novel coronavirus outbreak in neonatal intensive care units |pdf=|usr=}} | ||
+ | {{tp|p=32278357|t=2020. Lack of protective gear disrupts oncology care |pdf=|usr=}} | ||
+ | {{tp|p=32035509|t=2020. Coronavirus epidemic: preparing for extracorporeal organ support in intensive care |pdf=|usr=}} | ||
Zeile 180: | Zeile 217: | ||
*'''[[Economic aspects of the status hygienicus]]''' | *'''[[Economic aspects of the status hygienicus]]''' | ||
{{tp|p=32287365|t=2020. The Coming Coronavirus Crisis: What Can We Learn?|pdf=|usr=}} | {{tp|p=32287365|t=2020. The Coming Coronavirus Crisis: What Can We Learn?|pdf=|usr=}} | ||
+ | {{tp|p=32377508|t=ä. Review on government action plans to reduce energy consumption in buildings amid COVID-19 pandemic outbreak |pdf=|usr=}} | ||
+ | {{tp|p=32278363|t=2020. Softening the blow of the pandemic: will the International Monetary Fund and World Bank make things worse?|pdf=|usr=}} | ||
+ | {{tp|p=32119831|t=2020. Coronavirus outbreak: the role of companies in preparedness and responses |pdf=|usr=}} | ||
+ | |||
Zeile 189: | Zeile 230: | ||
*'''[[Host, vector, one health, atmospheric aspects]]''' | *'''[[Host, vector, one health, atmospheric aspects]]''' | ||
{{tp|p=32377932|t=ä. Animal-to-Human Viral Transitions: Is SARS-CoV-2 an Evolutionary Successful One?|pdf=|usr=}} | {{tp|p=32377932|t=ä. Animal-to-Human Viral Transitions: Is SARS-CoV-2 an Evolutionary Successful One?|pdf=|usr=}} | ||
− | + | *[https://archive.vn/gGbF2 goto mink farm 06/07/20] btu @SrsTwist | |
Zeile 201: | Zeile 242: | ||
{{tp|p=C7202836|t=ä. COVID-19 in Cameroon: a crucial equation to resolve |pdf=|usr=}} | {{tp|p=C7202836|t=ä. COVID-19 in Cameroon: a crucial equation to resolve |pdf=|usr=}} | ||
{{tp|p=C7202849|t=ä. COVID-19 on the African continent |pdf=|usr=}} | {{tp|p=C7202849|t=ä. COVID-19 on the African continent |pdf=|usr=}} | ||
− | + | {{tp|p=C7196395|t=ä. Contact Tracing to Manage COVID19 Spread ? Balancing Personal Privacy and Public Health |pdf=|usr=}} | |
− | + | {{tp|p=32386664|t=2020. COVID-19: The forgotten priorities of the pandemic |pdf=|usr=}} | |
− | + | {{tp|p=27402382|t=2016. (+)Super-spreading events of MERS-CoV infection |pdf=|usr=}} | |
+ | {{tp|p=32277875|t=2020. Pandemic school closures: risks and opportunities |pdf=|usr=}} | ||
+ | {{tp|p=32296776|t=2020. Crowdsourcing data to mitigate epidemics |pdf=|usr=}} | ||
+ | {{tp|p=32339471|t=2020. When pandemics collide |pdf=|usr=}} | ||
+ | {{tp|p=32171058|t=2020. The value of early transmission dynamic studies in emerging infectious diseases |pdf=|usr=}} | ||
+ | {{tp|p=27998579|t=2016. (+)Infectious disease emergencies: taking the long-term view |pdf=|usr=}} | ||
+ | {{tp|p=16631539|t=2006. (+)Deadly ?paleoviruses?: a bioweapon Pandora s box?|pdf=|usr=}} | ||
+ | {{tp|p=21272793|t=2011. (+)Urba" width="940" height="350" frameborder="0" scrolling="auto"> tion and infectious diseases in a globalised world |pdf=|usr=}} | ||
*'''[[Remission, recurrence and persistence]]''' | *'''[[Remission, recurrence and persistence]]''' | ||
Zeile 215: | Zeile 263: | ||
{{tp|p=32354343|t=2020. Evaluating the consequences of health policy decisions |pdf=|usr=}} | {{tp|p=32354343|t=2020. Evaluating the consequences of health policy decisions |pdf=|usr=}} | ||
{{tp|p=32380041|t=2020. COVID-19 immunity passports and vaccination certificates: scientific, equitable, and legal challenges |pdf=|usr=}} | {{tp|p=32380041|t=2020. COVID-19 immunity passports and vaccination certificates: scientific, equitable, and legal challenges |pdf=|usr=}} | ||
+ | {{tp|p=32087773|t=ä. Pandemic: examining readiness for infectious disease outbreaks |pdf=|usr=}} | ||
+ | |||
+ | |||
Zeile 234: | Zeile 285: | ||
{{ttp|p=32285349|t=ä. Reflections on life in the time of the Coronavirus pandemic, from the viewpoint of two people who have experienced dialysis and kidney transplantation |pdf=|usr=}} | {{ttp|p=32285349|t=ä. Reflections on life in the time of the Coronavirus pandemic, from the viewpoint of two people who have experienced dialysis and kidney transplantation |pdf=|usr=}} | ||
{{tp|p=C7130075|t=ä. Dr Hong Yu leads a team battling against the COVID-19 outbreak in Wuhan |pdf=|usr=}} | {{tp|p=C7130075|t=ä. Dr Hong Yu leads a team battling against the COVID-19 outbreak in Wuhan |pdf=|usr=}} | ||
+ | {{tp|p=32334691|t=2020. Offline: Why President Trump is wrong about WHO |pdf=|usr=}} | ||
+ | {{tp|p=27745880|t=2016. WHO s Director-General candidates: visions and priorities |pdf=|usr=}} | ||
+ | {{tp|p=32078809|t=2020. Outbreak of coronavirus disease 2019 |pdf=|usr=}} | ||
+ | {{ttp|p=32006509|t=2020. Mysterious pneumonia in China |pdf=|usr=}} | ||
+ | {{tp|p=32325013|t=2020. Can a virus undermine human rights?|pdf=|usr=}} | ||
+ | {{tp|p=32061319|t=2020. Authoritarianism, outbreaks, and information politics |pdf=|usr=}} | ||
+ | {{tp|p=32027848|t=2020. Coronavirus in China |pdf=|usr=}} | ||
*'''[[misc.]]''' | *'''[[misc.]]''' | ||
− | + | {{tp|p=32353307|t=2020. A new vehicle to accelerate the UN Sustainable Development Goals |pdf=|usr=}} | |
{{tp|p=C7173590|t=2015. Respiratory Syncytial Virus (RSV) |pdf=|usr=}} | {{tp|p=C7173590|t=2015. Respiratory Syncytial Virus (RSV) |pdf=|usr=}} | ||
{{tp|p=C7170204|t=2009. FERRETS |pdf=|usr=}} | {{tp|p=C7170204|t=2009. FERRETS |pdf=|usr=}} | ||
+ | {{tp|p=C7152207|t=2009. MICE AND RATS |pdf=|usr=}} | ||
+ | {{tp|p=16183520|t=2005. Meticillin-resistant Staphylococcus aureus |pdf=|usr=}} | ||
+ | {{tp|p=32078810|t=2020. Challenges of coronavirus disease 2019 |pdf=|usr=}} | ||
+ | {{tp|p=21557290|t=2011. Advances in mass spectrometry for the identification of pathogens |pdf=|usr=}} | ||
+ | |||
+ | |||
+ | |||
+ | |||
*'''[[Research tools]]'' | *'''[[Research tools]]'' |
Version vom 7. Juni 2020, 07:18 Uhr
- Further reading
- big link list published as a paper
- Unproven ideas
- uv emitting particles to be inhaled under dev in Russia
32122636 2020. (mayo)Guide to Understanding the 2019 Novel Coronavirus
32413768 2020. Covert COVID-19 complications: Continuing the use of evidence-based drugs to minimize potentially lethal indirect effects of the pandemic in stroke patients
32416414 2020. Genetic predisposition models to COVID-19 infection
C7200124 ä. Airway management for COVID-19: a move towards universal videolaryngoscope?
32444270 ä. Considerations for ventilator triage during the COVID-19 pandemic
30642777 2019. ECMO in severe acute respiratory distress syndrome
25209989 2014. ECMO as an emergency medical countermeasure
32006218 ä. Clinical role of viral identification by a polymerase chain reaction-based diagnostic panel in adults hospitalized with community-acquired pneumonia
C7194818 ä. Pooling of samples for testing for SARS-CoV-2 in asymptomatic people
32466975 ä. Rapid immunoglobulin test confirms a suspected case of COVID-19
C7190512 ä. El diagnostico COVID-19 a travs de la imagen
32402387 ä. ...ct thorax...
32421627 2020. The impact of biosensing in a pandemic outbreak: COVID-19
C7197557 ä. Selecting a SARS-CoV-2/COVID molecular testing method for your laboratory
32417029 ä. Pre- and post-treatment chest CT changes in a patient with COVID-19
32451080 ä. A possible strategy to fight COVID-19: Interfering with spike glycoprotein trimerization
32446559 2020. Stability of RNA sequences derived from the coronavirus genome in human cells
32073157 2020. Antibodies to coronaviruses are higher in older compared with younger adults and binding antibodies are more sensitive than neutralizing antibodies in identifying coronavirus?associated illnesses |
30715745 2019. (+)Th17 serum cytokines in relation to laboratory?confirmed respiratory viral infection: A pilot study
32408068 2020. What about the original antigenic sin of the humans versus SARS-CoV-2? |
32423585 2020. Is the HScore useful in COVID-19? index of hyperinflammation
31583825 2019. Improving immunological insights into the ferret model of human viral infectious disease
15892035 2005. An animal model of SARS produced by infection of Macaca mulatta with SARS coronavirus
16501078 2006. Modeling the Early Events of Severe Acute Respiratory Syndrome Coronavirus Infection In Vitro
C7149537 2008. (mech resp)Severe Acute Respiratory Syndrome (SARS)
32145185 2020. Middle East respiratory syndrome
C7195315 2020. Co-infections: potentially lethal and unexplored in COVID-19
32423586 2020. SARS-CoV-2 and influenza virus co-infection
C7190290 ä. (On embolism)Progressive respiratory failure in COVID-19: a hypothesis
C7177114 2020. Hypoxia in COVID-19: Sign of Severity or Cause for Poor Outcomes
32376101 2020. Association Between Hypoxemia and Mortality in Patients With COVID-19
32284281 2020. Hemoglobin value may be decreased in patients with severe coronavirus disease 2019
32448590 ä. Marked Up-Regulation of ACE2 in Hearts of Patients With Obstructive Hypertrophic Cardiomyopathy: Implications for SARS-CoV-2 Mediated COVID-19
32446685 ä. Acute pericarditis due to COVID-19 infection: An underdiagnosed disease?
32289035 2020. Dysosmia and dysgeusia due to the 2019 Novel Coronavirus; a hypothesis that needs further investigation
32402385 ä. Manifestaciones cutaneas ... un caso
32096611 2020. 2019 Novel coronavirus infection and gastrointestinal tract
32387057 ä. SARS-CoV-2 infection may result in appendicular syndrome: Chest CT scan before appendectomy
32377565 ä. COVID-19 and gastrointestinal tract
32204907 2020. The Novel Coronavirus 2019 epidemic and kidneys |
32388230 2020. Covid-19 infection in therapy-naive patients with B-cell chronic lymphocytic leukemia
32389426 2020. A favorable outcome of pneumonia COVID 19 in an advanced lung cancer patient with severe neutropenia: ...
32376099 2020. Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019
32475616 ä. copd w covid....
32232784 ä. A woman with fever and cough: coronavirus disease 2019
32061312 2020. First imported case of 2019 novel coronavirus in Canada, presenting as mild pneumonia
32123993 ä. Clinical features and short-term outcomes of 18 patients with corona virus disease 2019 in intensive care unit
32092387 2020. Clinical features of atypical 2019 novel coronavirus pneumonia with an initially negative RT-PCR assay
32451119 2020. The Early Natural History of SARS-CoV-2 Infection: Clinical Observations From an Urban, Ambulatory COVID-19 Clinic
32377641 2020. Initial data from the COVID-19 Global Rheumatology Alliance provider registries
32377642 2020. Initial data from the COVID-19 Global Rheumatology Alliance provider registries ? Authors reply
32353329 2020. An international registry for emergent pathogens and pregnancy
32292626 ä. Core Outcome Set for Clinical Trials on Coronavirus Disease 2019 (COS-COVID)
C7202831 ä. Testing COVID-19 therapies to prevent progression of mild disease
C7202844 ä. Vaccine development during global epidemics: the Zika experience
32380023 ä. Immunomodulation in COVID-19
32444269 ä. Immunotherapies for COVID-19: lessons learned from sepsis
32409074 2020. An overview of functional nanoparticles as novel emerging antiviral therapeutic agents
C7190528 ä. Treatment Considerations for COVID-19: A Critical Review of the Evidence (or Lack Thereof)
32386744 ä. Uso de antipaludicos (antimalarials)...
32408073 2020. Lithium for the 2019 novel coronavirus
32416413 2020. Covid-19 management with inflammation resolving mediators? Perspectives and potential
32408070 2020. Does zinc supplementation enhance the clinical efficacy of chloroquine/hydroxychloroquine to win todays battle against COVID-19?
32373787 2020. A new paradigm for drug development
32359447 2020. The resurgence of convalescent plasma therapy
32325038 ä. (+)Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial
32325036 ä. Two Middle East respiratory syndrome vaccines: first step for other coronavirus vaccines?
29329956 2018. Herd immunity: hyperimmune globulins for the 21st century |
31351923 2019. (+)First clinical trial of a MERS coronavirus DNA vaccine
28664850 2017. (+)Novel translational approaches to the search for precision therapies for acute respiratory distress syndrome
32373790 2020. Silencing the cytokine storm: the use of intravenous anakinra in haemophagocytic lymphohistiocytosis or macrophage activation syndrome
29852530 2020. The expanding role of mass spectrometry in the field of vaccine development
32376320 ä. Severe acute respiratory syndrome coronavirus 2 detection in the female lower genital tract
32388248 2020. COVID-19: The environmental implications of shedding SARS-CoV-2 in human faeces
32482249 2020. No evidence of severe acute respiratory syndrome?coronavirus 2 in semen of males recovering from coronavirus disease 2019
C7190296 2020. The experiences of health-care providers during the COVID-19 crisis in China: a qualitative study
C7201192 ä. Leadership, Management and Command in the time of the Coronavirus
32416433 2020. Metronomic oral vinorelbine and lung cancer therapy during the COVID 19 pandemic: A single-center experience
C7202360 ä. Lung cancer management challenges amidst COVID-19 pandemic: hope lives here
C7200366 2020. Managing thromboembolic risk with menopausal hormone therapy and hormonal contraception....
32414550 2020. ST-segment Elevation, Myocardial Injury, and Suspected or Confirmed COVID-19 Patients: Diagnostic and Treatment Uncertainties
32376104 2020. Public Health Crises and the Human Subjects of Biomedical Research: A Focus on COVID-19
32343347 ä. A Simple Technique for Droplet Control During Mastoid Surgery
32043976 2020. A contingency plan for the management of the 2019 novel coronavirus outbreak in neonatal intensive care units
32278357 2020. Lack of protective gear disrupts oncology care
32035509 2020. Coronavirus epidemic: preparing for extracorporeal organ support in intensive care
32387715 ä. Addressing Faculty Emotional Responses during the Coronavirus 2019 Pandemic
32454398 2020. STEMI during the COVID-19 Pandemic - An Evaluation of Incidence
32389608 ä. Heart Failure in the COVID-19 Pandemic: Where has all New York s congestion gone?
32387671 2020. Role of the chronic air pollution levels in the Covid-19 outbreak risk in Italy? |
C7188145 ä. Reporting, Recording and Communication of COVID-19 Cases in Workplace: Data Protection as a Moving Target
32287365 2020. The Coming Coronavirus Crisis: What Can We Learn?
32377508 ä. Review on government action plans to reduce energy consumption in buildings amid COVID-19 pandemic outbreak
32278363 2020. Softening the blow of the pandemic: will the International Monetary Fund and World Bank make things worse?
32119831 2020. Coronavirus outbreak: the role of companies in preparedness and responses
32377932 ä. Animal-to-Human Viral Transitions: Is SARS-CoV-2 an Evolutionary Successful One?
- goto mink farm 06/07/20 btu @SrsTwist
C7175784 ä. Pros and cons of the application of evolutionary theories to the evolution of SARS-CoV-2
C7195296 ä. Limiting the spread of COVID-19 in Africa: one size mitigation strategies do not fit all countries
C7202836 ä. COVID-19 in Cameroon: a crucial equation to resolve
C7202849 ä. COVID-19 on the African continent
C7196395 ä. Contact Tracing to Manage COVID19 Spread ? Balancing Personal Privacy and Public Health
32386664 2020. COVID-19: The forgotten priorities of the pandemic
27402382 2016. (+)Super-spreading events of MERS-CoV infection
32277875 2020. Pandemic school closures: risks and opportunities
32296776 2020. Crowdsourcing data to mitigate epidemics
32339471 2020. When pandemics collide
32171058 2020. The value of early transmission dynamic studies in emerging infectious diseases
27998579 2016. (+)Infectious disease emergencies: taking the long-term view
16631539 2006. (+)Deadly ?paleoviruses?: a bioweapon Pandora s box?
21272793 2011. (+)Urba" width="940" height="350" frameborder="0" scrolling="auto"> tion and infectious diseases in a globalised world
32389787 ä. Reactivation of COVID-19 pneumonia: A report of two cases
32416370 2020. Has COVID-19 played an unexpected ?stroke? on the chain of survival?
32354343 2020. Evaluating the consequences of health policy decisions
32380041 2020. COVID-19 immunity passports and vaccination certificates: scientific, equitable, and legal challenges
32087773 ä. Pandemic: examining readiness for infectious disease outbreaks
32169251 2020. Ophthalmologists Are More Than Eye Doctors?In Memoriam Li Wenliang
C7137172 2020. Li Wenliang
32033382 2020. Does Wuhan Need to be in Lockdown during the Chinese Lunar New Year?
32285349 ä. Reflections on life in the time of the Coronavirus pandemic, from the viewpoint of two people who have experienced dialysis and kidney transplantation |
C7130075 ä. Dr Hong Yu leads a team battling against the COVID-19 outbreak in Wuhan
32334691 2020. Offline: Why President Trump is wrong about WHO
27745880 2016. WHO s Director-General candidates: visions and priorities
32078809 2020. Outbreak of coronavirus disease 2019
32006509 2020. Mysterious pneumonia in China |
32325013 2020. Can a virus undermine human rights?
32061319 2020. Authoritarianism, outbreaks, and information politics
32027848 2020. Coronavirus in China
32353307 2020. A new vehicle to accelerate the UN Sustainable Development Goals
C7173590 2015. Respiratory Syncytial Virus (RSV)
C7170204 2009. FERRETS
C7152207 2009. MICE AND RATS
16183520 2005. Meticillin-resistant Staphylococcus aureus
32078810 2020. Challenges of coronavirus disease 2019
21557290 2011. Advances in mass spectrometry for the identification of pathogens
27490990 2017. AVCpred: an integrated web server for prediction and design of antiviral compounds
- from the ads
- [aumbiotech.com rnai self-delivering]
- [synthego.com crispr cell lines]
- Current state of coviki.org
- on-topic personal thoughts